In this video, Matthew C. Tattersall, DO, MS, discusses persistent asthma and its association with carotid plaque burden, which is a strong predictor of atherosclerotic cardiovascular disease events, in the...
In this video, Shaan Khurshid, MD, MPH, talks about his team's study that analyzed a database of nearly 90,000 people and found that concentrated physical activity (1-2 days per week) offers similar heart...
In this video, cardiologists Seth Martin, MD, MHS, and Jessica Golbus, MD, speak with Sarah Riley, MSN, CRNP, CHFN, and Michael Dorsch, PharmD, MS, in a roundtable discussion on the role of a...
In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
03/05/2024
Multidisciplinary Dialogue: Clinical Rounds and Case Reviews, Ep. 15
Multidisciplinary Dialogue: Clinical Rounds and Case Reviews, Ep. 15
In this podcast, Anil Harrison, MD, and Paul Shiu, DO, discuss how to evaluate a patient with newly diagnosed hypertension, pharmacological and non-pharmacological interventions available for patients...
In this podcast, Alan S. Go, MD, discusses the results of his recent study, which examined the relationship between HIV, heart failure, and patient demographics.
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
In this video, Michael J. Bloch, MD, discusses cardiovascular disease in women, including a woman's premenopausal life and its impact on cardiovascular disease risk post-menopausally and the management of...
In this article, Michael J. Bloch, MD, writes about the results of the recently published BrightHTN study, which examined the use of the investigational aldosterone synthase inhibitor baxdrostat in patients...